Conray 30 and Mogamulizumab-kpkc Intravenous
Determining the interaction of Conray 30 and Mogamulizumab-kpkc Intravenous and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: iothalamate
Brand name: Conray, Conray 30, Conray 43, Cysto-Conray II
Synonyms: Iothalamate Meglumine
Generic Name: mogamulizumab
Brand name: Poteligeo
Synonyms: Mogamulizumab
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Conray 30-Molindone
- Conray 30-Mometasone (Oral Inhalation)
- Conray 30-Mometasone and Formoterol
- Conray 30-Mometasone and formoterol Inhalation
- Conray 30-Mometasone Cream
- Conray 30-Mometasone Furoate
- Mogamulizumab-kpkc Intravenous-Conray 400
- Mogamulizumab-kpkc Intravenous-Conray 43
- Mogamulizumab-kpkc Intravenous-Consensi
- Mogamulizumab-kpkc Intravenous-Constulose
- Mogamulizumab-kpkc Intravenous-Contac 12-Hour
- Mogamulizumab-kpkc Intravenous-Contac Cold